US Tariffs Today, March 13: Section 301 Probe Targets Switzerland, EU

Donald Trump tariffs are back in focus for Switzerland as the U.S. launches Section 301 investigations into 16 partners, including Bern and the EU. The Supreme Court voided prior IEEPA tariffs, so Washington is pivoting to Section 301. Written comments are due by 15 April, hearings start 5 May, and completion is targeted by end-July as Section 122’s blanket 10% tariffs lapse. We explain what this means for Switzerland trade, sector exposure, and how investors can position around Donald Trump tariffs.

What the new Section 301 probes cover

The U.S. opened a Section 301 investigation after the Supreme Court struck down earlier IEEPA tariffs. The docket sets comments by 15 April, hearings from 5 May, and a goal to finish by end-July. That aligns with the sunset of Section 122’s 10% blanket tariffs. See Swiss coverage for context at US-Regierung: Neue Untersuchungen der Handelspartner geplant.

Section 301 enables targeted duties on specific goods if unfair practices are found. Prior U.S. rules often spared pharmaceuticals, which matters for Swiss exporters. Watches, machinery, specialty chemicals, and medtech accessories could face review. EU measures might ripple into Swiss supply chains. Read more in NZZ: Trump bereitet die nächsten Zölle vor – und nimmt auch die Schweiz und die EU wieder ins Visier. Donald Trump tariffs would vary by product and finding.

Why it matters for Swiss exporters and CHF portfolios

Tariffs can lift landed costs, compress margins, and slow orders. Swiss firms with high U.S. revenue or limited pricing power are most exposed. Supply chains that transit the EU face added complexity. If duties hit precision goods, pass-through could be difficult. Investors should map U.S. share of sales and HS codes. Donald Trump tariffs could shift Switzerland trade volumes and mix.

The franc often firms in risk-off periods, pressuring foreign earnings once converted. In U.S. equities, ^GSPC recently printed 6644.6, down 1.94% on the day, with RSI at 35.2 and price below the lower Bollinger band of 6714.5. Such readings flag fragile sentiment. A stronger CHF and softer U.S. demand can compound tariff effects on Swiss exporters if Donald Trump tariffs broaden.

Scenarios and sector implications by July

Base case: narrow, product-specific actions following hearings, with scope refined by comments due 15 April. Downside: broader US tariffs that raise compliance costs and invite EU countermeasures. Upside: negotiated adjustments that limit coverage or timing. Completion is targeted by end-July as Section 122 lapses, keeping policy risk elevated. Donald Trump tariffs remain the market’s main swing factor.

Pharmaceuticals were historically spared, though inputs could still face checks. Watches, machinery, precision tools, and medtech accessories look more exposed to targeted tariffs. EU auto and industrial measures could spill into Swiss suppliers. Service providers with U.S. clients might see contract re-pricing. Investors should stress test revenue, margin, and inventory days under low, medium, and high-duty assumptions.

How Swiss investors can prepare now

Reduce single-market revenue concentration, add CHF cash or ultra-short CHF bonds for optionality, and review USD hedges. Consider protective puts around U.S.-exposed names into the May hearings window. Rebalance toward firms with diversified end-markets and strong pricing power. Track real-time tariff headlines closely, since Donald Trump tariffs can shift quickly with docket updates.

Ask companies about tariff contingency planning, including supplier rerouting, country-of-origin documentation, and alternative finishing locations. Confirm HS code mapping and broker readiness for rapid duty changes. Review inventory buffers for U.S.-destined goods. Encourage scenario planning for 0 to high single-digit duty shocks. Clear, audited data will help management respond fast if US tariffs widen post-hearings.

Final Thoughts

Switzerland faces a defined but fast-moving timetable. Comments by 15 April, hearings from 5 May, and a targeted end-July wrap create catalysts that can move prices and the franc. Map HS codes, U.S. revenue shares, and pricing power across holdings. Monitor signals from Section 301 findings and any EU responses. Use hedges and liquidity to cushion volatility. If Donald Trump tariffs stay narrow and targeted, disruption should be manageable. If Donald Trump tariffs broaden, expect tighter margins, slower orders, and a premium on firms with resilient demand, flexible sourcing, and clean trade documentation. Staying data-driven and active will matter most.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.